Rasagiline Mesylate

CAS 161735-79-1 14 current records 4 historicalSmall Molecule

Who holds supplier records for Rasagiline Mesylate? 14 organisations hold a current record for Rasagiline Mesylate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9), Malta (1), Taiwan (1) and Argentina (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Rasagiline Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/rasagiline-mesylate

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rasagiline Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India9Malta1Taiwan1Argentina1Country not recorded for 2
Need Rasagiline Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Rasagiline Mesylate are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rasagiline Mesylate is a selective, irreversible monoamine oxidase-B inhibitor used in the treatment of Parkinson's disease. It helps to increase and sustain the levels of dopamine in the brain, thus improving motor symptoms associated with the disease.

Chemical identity

IUPAC name
methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
Canonical SMILES
CS(=O)(=O)O.C#CCN[C@@H]1CCC2=CC=CC=C12
InChIKey
JDBJJCWRXSVHOQ-UTONKHPSSA-N
Synonyms
Azilect API, agilect, azilect, rasagiline (as mesilate), rasagiline mesilate, rasagiline methanesulfonate, rasagline ratiopharm, tvp-1012

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Monoamine Oxidase Inhibitor
Mechanism of action
Monoamine Oxidase Inhibitors

Therapeutic areas

NeurologyParkinson's Disease

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rasagiline Mesylate?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Rasagiline Mesylate: ALIVUS LIFE SCIENCES LTD (India), Alkem Laboratories Limited (India), Amino Chemicals Ltd (Malta), Dr. Reddy's Laboratories Ltd. (India), EVERLIGHT CHEMICAL INDUSTRIAL CORP (Taiwan), INDOCO REMEDIES LTD (India), Macleods Pharmaceuticals Ltd. (India) and MAPRIMED SA (Argentina), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rasagiline Mesylate Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 26599), Alkem Laboratories Limited (DMF 23679), Amino Chemicals Ltd (DMF 22667), Dr. Reddy's Laboratories Ltd. (DMF 23460), EVERLIGHT CHEMICAL INDUSTRIAL CORP (DMF 25630), INDOCO REMEDIES LTD (DMF 27634), Macleods Pharmaceuticals Ltd. (DMF 26706) and MAPRIMED SA (DMF 25366) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rasagiline Mesylate records mean?

4 organisations have only inactive Type II DMFs for Rasagiline Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Rasagiline Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rasagiline Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.